GO:0052833 inositol monophosphate 4-phosphatase activity

GO:0052833, inositol monophosphate 4-phosphatase activity, is a molecular function defined by the catalysis of the reaction 1D-myo-inositol 4-phosphate + H2O = myo-inositol + phosphate. In practical terms, it is the enzymatic removal of a phosphate group from an inositol monophosphate substrate, releasing free myo-inositol and inorganic phosphate. This activity belongs to the wider family of inositol monophosphatases and lipid phosphatases that regulate phosphoinositide metabolism and inositol homeostasis. Because phosphoinositides are central to membrane trafficking, cytoskeletal dynamics, and signal transduction, enzymes with this activity can influence many downstream cellular processes. The reaction described by GO:0052833 is chemically straightforward but physiologically important. Inositol monophosphates are generated during the turnover of phosphatidylinositol and its phosphorylated derivatives, and their dephosphorylation helps recycle inositol and terminate or modulate lipid-derived signals. Studies in plants provided early evidence for substrate cycling of 3-, 3,4-, 4-, and 4,5-phosphorylated phosphatidylinositols, indicating that inositol phosphate phosphatases are active in diverse eukaryotic systems. In parallel, bacterial pathogens can manipulate host phosphoinositide lipids through phosphatase effectors, as shown for the Shigella flexneri effector IpgD, which converts PtdIns(4,5)P2 into PtdIns(5)P and reorganizes host cell morphology. For researchers, GO:0052833 provides a precise annotation for genes and proteins that catalyze this dephosphorylation step. It is especially relevant when studying phosphoinositide signaling, membrane dynamics, and cancer cell behavior, because related lipid phosphatases such as INPP4B control pancreatic cancer cell migration and invasion by regulating fibronectin exocytosis. Understanding this activity therefore connects basic enzymology to disease-relevant cell biology.

GO:0052833, inositol monophosphate 4-phosphatase activity, is defined by QuickGO as the catalysis of the reaction: 1D-myo-inositol 4-phosphate + H2O = myo-inositol + phosphate. In other words, it is a phosphatase activity that removes the phosphate group from an inositol monophosphate molecule, specifically acting on the 4-position of 1D-myo-inositol 4-phosphate, to produce free myo-inositol and inorganic phosphate. The term is classified as a molecular_function and is also known by synonyms including inositol-1(or 4)-monophosphatase activity, myo-inositol-1(or 4)-monophosphatase activity, and myo-inositol-1(or 4)-phosphate phosphohydrolase activity.

GO:0052833 matters because it captures a specific enzymatic step in inositol and phosphoinositide metabolism, a pathway that controls membrane identity, signal transduction, and cytoskeletal organization. The reaction converts 1D-myo-inositol 4-phosphate into myo-inositol and phosphate, thereby contributing to inositol recycling and to the termination or modulation of inositol phosphate signals. Related phosphatase activities can be subverted by pathogens, as illustrated by the Shigella flexneri effector IpgD, which converts PtdIns(4,5)P2 into PtdIns(5)P and reorganizes host cell morphology. In cancer, the lipid phosphatase INPP4B controls pancreatic cancer cell migration and invasion by regulating fibronectin exocytosis, demonstrating that this enzyme family can directly influence tumor cell behavior. Consequently, annotating and studying GO:0052833 helps researchers connect molecular catalysis to cell biology and disease.

The following genes and proteins are relevant to inositol monophosphate 4-phosphatase activity and its related phosphoinositide phosphatase biology, based on the verified literature.

Regulation of inositol monophosphate 4-phosphatase activity is not fully captured by the QuickGO definition, which describes only the catalytic reaction. However, the broader phosphoinositide phosphatase network is regulated by substrate availability, membrane recruitment, and protein-protein interactions. For example, the lipid phosphatase INPP4B controls pancreatic cancer cell migration and invasion by regulating fibronectin exocytosis, indicating that its activity is integrated into cancer cell signaling programs. In addition, bacterial effectors such as IpgD can be delivered into host cells to convert PtdIns(4,5)P2 into PtdIns(5)P, showing that phosphatase activity can be regulated by pathogen secretion and host membrane targeting. In plants, substrate cycling of 3-, 3,4-, 4-, and 4,5-phosphorylated phosphatidylinositols suggests that inositol phosphate phosphatase activities are dynamically regulated during lipid turnover.

The lipid phosphatase INPP4B controls pancreatic cancer cell migration and invasion by regulating fibronectin exocytosis. This finding links the broader family of inositol/lipid phosphatases to tumor cell behavior and suggests that related enzymes, including those annotated with GO:0052833, may influence cancer progression through phosphoinositide signaling.

The Shigella flexneri effector IpgD converts PtdIns(4,5)P2 into PtdIns(5)P and reorganizes host cell morphology. This demonstrates that bacterial pathogens can manipulate host phosphoinositide lipids through phosphatase activities, highlighting the importance of understanding dephosphorylation reactions in infection biology.

Evidence for substrate cycling of 3-, 3,4-, 4-, and 4,5-phosphorylated phosphatidylinositols in plants indicates that inositol phosphate phosphatases are active in lipid turnover pathways. Disruption of such recycling could affect membrane lipid homeostasis and downstream signaling, although direct disease associations for GO:0052833 specifically require further study.

Enzymatic activity can be measured using inositol monophosphate substrates and detection of released phosphate. Such assays directly test the reaction described by GO:0052833 and can be applied to lysates from CRISPR knockout or overexpression cells.

Mass spectrometry or chromatographic profiling of inositol phosphates and phosphoinositides can reveal changes in substrate and product levels. This approach is supported by evidence for substrate cycling of phosphorylated phosphatidylinositols in plants and by the conversion of PtdIns(4,5)P2 into PtdIns(5)P by IpgD.

Because INPP4B controls pancreatic cancer cell migration and invasion by regulating fibronectin exocytosis, migration and invasion assays are useful for testing whether related phosphatases affect cancer cell behavior.

Live-cell imaging of phosphoinositide reporters and cytoskeletal markers can show how phosphatase activity alters cell morphology. This is relevant because IpgD-mediated conversion of PtdIns(4,5)P2 into PtdIns(5)P reorganizes host cell morphology.

Researchers studying inositol monophosphate 4-phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in phosphoinositide signaling, inositol recycling, or disease-relevant cell behaviors such as migration and invasion. EDITGENE provides CRISPR-based cell model services to support these investigations.

GO:0052833, inositol monophosphate 4-phosphatase activity, defines a specific dephosphorylation reaction that converts 1D-myo-inositol 4-phosphate into myo-inositol and phosphate. This activity sits within a broader network of inositol and phosphoinositide phosphatases that regulate lipid turnover, membrane signaling, and cell behavior. Related lipid phosphatases such as INPP4B can control cancer cell migration and invasion, and bacterial effectors such as IpgD can reorganize host cell morphology through phosphoinositide conversion. Studying GO:0052833 with CRISPR-based models therefore offers a direct route to connect molecular catalysis with disease-relevant cell biology.